4.7 Article

Synthetic prions with novel strain-specified properties

Journal

PLOS PATHOGENS
Volume 11, Issue 12, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.ppat.1005354

Keywords

-

Funding

  1. European Community [222887]
  2. Ministero dell'Istruzione, dell'Universita e della Ricerca
  3. Italian Ministry of Health

Ask authors/readers for more resources

Prions are infectious proteins that possess multiple self-propagating structures. The information for strains and structural specific barriers appears to be contained exclusively in the folding of the pathological isoform, PrPSc. Many recent studies determined that de novo prion strains could be generated in vitro from the structural conversion of recombinant (rec) prion protein (PrP) into amyloidal structures. Our aim was to elucidate the conformational diversity of pathological recPrP amyloids and their biological activities, as well as to gain novel insights in characterizing molecular events involved in mammalian prion conversion and propagation. To this end we generated infectious materials that possess different conformational structures. Our methodology for the prion conversion of recPrP required only purified rec full-length mouse (Mo) PrP and common chemicals. Neither infected brain extracts nor amplified PrPSc were used. Following two different in vitro protocols recMoPrP converted to amyloid fibrils without any seeding factor. Mouse hypothalamic GT1 and neuroblastoma N2a cell lines were infected with these amyloid preparations as fast screening methodology to characterize the infectious materials. Remarkably, a large number of amyloid preparations were able to induce the conformational change of endogenous PrPC to harbor several distinctive proteinase-resistant PrP forms. One such preparation was characterized in vivo habouring a synthetic prion with novel strain specified neuropathological and biochemical properties.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Cell Biology

Therapeutic strategies for identifying small molecules against prion diseases

Elisa Uliassi, Lea Nikolic, Maria Laura Bolognesi, Giuseppe Legname

Summary: This article reviews the major advances in prion drug discovery, including the identification of anti-prion small molecules through screening methods, as well as the discovery of novel compounds with expanded anti-prion profiles through multi-target-directed ligand (MTDLs) strategies and theranostics.

CELL AND TISSUE RESEARCH (2023)

Article Medicine, General & Internal

Validation of Revised International Creutzfeldt-Jakob Disease Surveillance Network Diagnostic Criteria for Sporadic Creutzfeldt-Jakob Disease

Neil Watson, Peter Hermann, Anna Ladogana, Angeline Denouel, Simone Baiardi, Elisa Colaizzo, Giorgio Giaccone, Markus Glatzel, Alison J. E. Green, Stephane Haik, Daniele Imperiale, Janet MacKenzie, Fabio Moda, Colin Smith, David Summers, Dorina Tiple, Luana Vaianella, Gianluigi Zanusso, Maurizio Pocchiari, Inga Zerr, Piero Parchi, Jean-Philippe Brandel, Suvankar Pal

Summary: This diagnostic study demonstrated significantly improved sensitivity of revised sCJD diagnostic criteria with unaltered specificity. The revision has enhanced diagnostic accuracy for clinical care and surveillance.

JAMA NETWORK OPEN (2022)

Article Clinical Neurology

DNAJB2-related Charcot-Marie-Tooth disease type 2: Pathomechanism insights and phenotypic spectrum widening

Paola Saveri, Stefania Magri, Emanuela Maderna, Francesca Balistreri, Raffaella Lombardi, Claudia Ciano, Fabio Moda, Barbara Garavaglia, Chiara Reale, Giuseppe Lauria Pinter, Franco Taroni, Davide Pareyson, Chiara Pisciotta

Summary: We describe a family with CMT2 caused by a homozygous DNAJB2 mutation and provide insights into the pathomechanisms. The mutation leads to severe muscle weakness, loss of movement, and reduced sensation in the lower limbs. Patients also exhibit severe hearing loss and one patient has Parkinson's disease. The study reveals reduced levels of DNAJB2 mRNA and protein, as well as the presence of phospho-alpha-synuclein deposits and TDP-43 accumulation in the patients.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Article Neurosciences

Serpin Signatures in Prion and Alzheimer's Diseases

Marco Zattoni, Marika Mearelli, Silvia Vanni, Arianna Colini Baldeschi, Thanh Hoa Tran, Chiara Ferracin, Marcella Catania, Fabio Moda, Giuseppe Di Fede, Giorgio Giaccone, Fabrizio Tagliavini, Gianluigi Zanusso, James W. Ironside, Isidre Ferrer, Giuseppe Legname

Summary: This study investigated the differential expression of serpin superfamily members in neurodegenerative diseases. The results showed dysregulation of SERPINB1, SERPINB6, SERPING1, SERPINH1, and SERPINI1 in sCJD individuals compared to controls, while only SERPINB1 was upregulated in AD patients. Additionally, SerpinA3n transcript and protein were upregulated in a mouse model of AD. These findings suggest that SERPINA3/SerpinA3n may be a potential therapeutic target for the treatment of prion and prion-like neurodegenerative diseases.

MOLECULAR NEUROBIOLOGY (2022)

Correction Clinical Neurology

The cognitive phenotypes of Creutzfeldt-Jakob disease: comparison with secondary metabolic encephalopathy (Jan, 10.1007/s10072-021-05795-x, 2022)

Anna Rita Giovagnoli, Giuseppe Di Fede, Giacomina Rossi, Fabio Moda, Marina Grisoli, Orso Bugiani

NEUROLOGICAL SCIENCES (2022)

Article Geriatrics & Gerontology

PMCA-Based Detection of Prions in the Olfactory Mucosa of Patients With Sporadic Creutzfeldt-Jakob Disease

Federico Angelo Cazzaniga, Edoardo Bistaffa, Chiara Maria Giulia De Luca, Sara Maria Portaleone, Marcella Catania, Veronica Redaelli, Irene Tramacere, Giuseppe Bufano, Martina Rossi, Paola Caroppo, Anna Rita Giovagnoli, Pietro Tiraboschi, Giuseppe Di Fede, Roberto Eleopra, Grazia Devigili, Antonio Emanuele Elia, Roberto Cilia, Michele Fiorini, Matilde Bongianni, Giulia Salzano, Luigi Celauro, Federico Giuseppe Quarta, Angela Mammana, Giuseppe Legname, Fabrizio Tagliavini, Piero Parchi, Gianluigi Zanusso, Giorgio Giaccone, Fabio Moda

Summary: Sporadic Creutzfeldt-Jakob disease (sCJD) is a rare neurodegenerative disorder caused by the conformational conversion of the prion protein. The PMCA technique can detect PrPSc in the olfactory mucosa and estimate its concentration. Optimizing PMCA is important for diagnosis and selection of patients for clinical trials.

FRONTIERS IN AGING NEUROSCIENCE (2022)

Review Clinical Neurology

alpha-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies The Way Forward

Giovanni Bellomo, Chiara Maria Giulia De Luca, Federico Paolini Paoletti, Lorenzo Gaetani, Fabio Moda, Lucilla Parnetti

Summary: Parkinson disease (PD) is a common neurodegenerative disease associated with misfolding and aggregation of alpha-synuclein. Seed amplification assays (SAAs) can detect misfolded alpha-synuclein in patients with PD and are promising diagnostic biomarkers. However, standardization issues need to be addressed.

NEUROLOGY (2022)

Article Chemistry, Medicinal

Bifunctional carbazole derivatives for simultaneous therapy and fluorescence imaging in prion disease murine cell models

Matteo Staderini, Silvia Vanni, Arianna Colini Baldeschi, Gabriele Giachin, Marco Zattoni, Luigi Celauro, Chiara Ferracin, Edoardo Bistaffa, Fabio Moda, Daniel Perez, Ana Martinez, M. Antonia Martin, Olmo Martin-Camara, Angel Cores, Giulia Bianchini, Robert Kammerer, J. Carlos Menendez, Giuseppe Legname, Maria Laura Bolognesi

Summary: This study designed novel carbazole derivatives as pharmacological chaperones for prion diseases. These derivatives showed anti-prion activity and could detect prion protein aggregates through fluorescent staining. The compounds exhibited activity against RML-infected cell lines and have potential applications in the treatment of prion diseases.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Review Biochemistry & Molecular Biology

Copper coordination modulates prion conversion and infectivity in mammalian prion proteins

Giuseppe Legname

Summary: In mammals, the prion protein (PrPC) is a common protein involved in various functions in the central nervous system. It also plays a central role in prion diseases, a group of fatal neurodegenerative disorders. The protein can convert into an infectious form called prion and its unique structure, including octarepeat sequences and copper binding sites, may modulate prion conversion and replication.

PRION (2023)

Letter Clinical Neurology

Sporadic Fatal Insomnia presenting with agrypnia excitata and rapidly progressive dementia: a case report

Miryam Cannizzaro, Valentina Pieri, Davide Curti, Mor Gueye, Giulia Rugarli, Giovanni Napoli, Rosalinda Cardamone, Andrea Falini, Daniela Perani, Marco Zucconi, Francesca Casoni, Giorgio Giaccone, Fabio Moda, Giuseppe Di Fede, Giuseppe Magnani, Francesca Caso, Massimo Filippi

JOURNAL OF NEUROLOGY (2023)

Correction Geriatrics & Gerontology

PMCA-based detection of prions in the olfactory mucosa of patients with sporadic Creutzfeldt-Jakob disease(vol 14, 848991, 2022)

Federico Angelo Cazzaniga, Edoardo Bistaffa, Chiara Maria Giulia De Luca, Sara Maria Portaleone, Marcella Catania, Veronica Redaelli, Irene Tramacere, Giuseppe Bufano, Martina Rossi, Paola Caroppo, Anna Rita Giovagnoli, Pietro Tiraboschi, Giuseppe Di Fede, Roberto Eleopra, Grazia Devigili, Antonio Emanuele Elia, Roberto Cilia, Michele Fiorini, Matilde Bongianni, Giulia Salzano, Luigi Celauro, Federico Giuseppe Quarta, Angela Mammana, Giuseppe Legname, Fabrizio Tagliavini, Piero Parchi, Gianluigi Zanusso, Giorgio Giaccone, Fabio Moda

FRONTIERS IN AGING NEUROSCIENCE (2023)

Article Clinical Neurology

Detection of prions in the urine of patients affected by sporadic Creutzfeldt-Jakob disease

Sandra Pritzkow, Frank Ramirez, Adam Lyon, Paul E. Schulz, Brian Appleby, Fabio Moda, Santiago Ramirez, Silvio Notari, Pierluigi Gambetti, Claudio Soto

Summary: This study evaluated the presence of prions in the urine of patients with the major subtypes of sCJD. It found that 36% of patients tested positive for prions in their urine, indicating a potential risk for inter-individual transmission of infectious prions.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2023)

Article Biochemistry & Molecular Biology

Prion receptors, prion internalization, intra-and inter-cellular transport

Luigi Celauro, Marco Zattoni, Giuseppe Legname

Summary: Cellular prion protein plays a significant role in neurodegenerative diseases and can be taken up by neighboring cells. The intercellular routing of prion proteins involves the release through vesicles and nanotubes.

RECEPTOR ENDOCYTOSIS AND SIGNALLING IN HEALTH AND DISEASE, PT B (2023)

Article Chemistry, Multidisciplinary

Structural and dynamical determinants of a β-sheet-enriched intermediate involved in amyloid fibrillar assembly of human prion protein

Luigi Russo, Giulia Salzano, Andrea Corvino, Edoardo Bistaffa, Fabio Moda, Luigi Celauro, Gianluca D'Abrosca, Carla Isernia, Danilo Milardi, Gabriele Giachin, Gaetano Malgieri, Giuseppe Legname, Roberto Fattorusso

Summary: This study investigates the mechanism of thermal unfolding of human prion protein and reveals that the transient electrostatic interactions between the N- and C-terminal domains play a key role in regulating the folding process. The study also provides a clear molecular description of the initial phases of prion misfolding using fluorescence fibrillization assays.

CHEMICAL SCIENCE (2022)

No Data Available